Discovery is the key to advancing human health. Find out how our leading researchers are pioneering new, breakthrough solutions to some of the world’s most challenging health problems.
The day-long event outlined the journey from academic discovery to commercial development, highlighting recent startup successes at McMaster
Up to 40 per cent of global populations have a genetic predisposition to celiac disease, but only one per cent develops the autoimmune condition when exposed to dietary gluten. Elana Verdú’s research focuses on how this could be influenced by gut bacteria.
McMaster researchers have taken a significant step toward understanding how the most commonly prescribed form of anti-depressant medication actually works in the body, establishing a better understanding of the role of the gut in regulating mood and behaviour.
McMaster logo
